[1]
2024. Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: the value of the CARWL index. Biomolecules and Biomedicine. (Sep. 2024). DOI:https://doi.org/10.17305/bb.2024.11155.